Premium
Paxillin expression levels are correlated with clinical stage and metastasis in salivary adenoid cystic carcinoma
Author(s) -
Shi Jinna,
Wang Shan,
Zhao Eryang,
Shi Lei,
Xu Xin,
Fang Ming
Publication year - 2010
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.2009.00859.x
Subject(s) - paxillin , adenoid cystic carcinoma , metastasis , pathology , stage (stratigraphy) , immunohistochemistry , biology , carcinoma , medicine , cancer research , cancer , focal adhesion , cell , paleontology , genetics
J Oral Pathol Med (2010) 39 : 548–551 Aims: To investigate the relationship between paxillin expression and clinicopathological features and metastasis in salivary adenoid cystic carcinoma (SACC). Methods: A total of 47 SACC were assessed histochemically for paxillin expression. Paxillin immunoreactivity was compared with histological type, clinical stage and distant metastasis. Results: Paxillin expression was identified in 57.45% of SACC as cytoplasmic staining and the expression was correlated with distant metastasis and clinical stage ( P < 0.05), but not with histological type. Conclusions: Our observations indicate that paxillin expression is upregulated in SACC. High expression of paxillin was correlated with a more advanced stage and metastasis in SACC, suggesting that paxillin is a disease marker in advanced SACC and SACC with distant metastasis, and, consequently, may have value as a therapeutic target for SACC.